Woman health and breast cancer. Interview with Dr Antonella Ferro (APSS - Trento - Italy) [ENGL version]

Ospitiamo tra le nostre produzioni audio, l'episodio in lingua inglese titolato "Woman health and breast cancer" prodotto da "The Podcasters" (De Podcasters) [e-mail]
e moderato da Alexis Strader ([e-mail]), tradotto da Olivia Balagna (PAT - Trento).
Podcast realizzato nell'ambito del progetto #EUVECA Program.
******************************
Incipit del podcast: Welcome to "Tailored by DNA: The Future of Personalized Medicine"– the first edition in five-part podcast series under the #EUVECA Program, exploring the evolving landscape of personalized medication. 
In this series, we’ll dive into the exciting and complex world of precision medicine, touching on everything from cutting-edge drug development to the ethical, technological, and clinical
challenges shaping this new frontier. Today, we begin by focusing on how genomics and personalized targeting are reshaping the way medications are developed – moving away from the traditional "one-size-fits-all" model and toward treatments designed specifically for the individual.
As healthcare shifts toward more patient-centered solutions, we’ll unpack how personal genomes, biomarkers, and advanced technologies are influencing the medications of tomorrow. This episode will set the stage, introducing the foundations of personalized medicine, with insights from industry leaders and innovators who are pioneering this transformation. Whether you’re a healthcare professional, a patient, or simply curious about the future of medicine, this series will offer a closer
look at how personalized care is driving better outcomes and transforming lives across Europe and beyond. Let’s kick things off and explore what the future holds for tailored treatments.
Hello and welcome, I’m Alexis Strader of the European Health Advancement Movement (EHAM), and I’ll be your host throughout this series. In each episode, we’ll be joined by a new guest speaker,
offering fresh insights into the evolving world of precision medicine – from drug development to patient care. Today, I’m thrilled to introduce [Antonella Ferro– First level medical director, specialist in medical oncology / Breast Unit clinical network co-ordinator / Head of simple structure oncology in for the Trento Healthcare Trust called APSS (Azienda Provinciale per i Servizi Sanitari)], who will join me for an engaging conversation about the Breast Cancer Unit of Trento Italy.